Interaction of nucleotide excision repair protein XPC—RAD23B with DNA containing benzo[a]pyrene-derived adduct and apurinic/apyrimidinic site within a cluster
- Authors: Starostenko L.V.1, Maltseva E.A.1, Lebedeva N.A.1,2, Pestryakov P.E.1, Lavrik O.I.1,2, Rechkunova N.I.1,2
-
Affiliations:
- Institute of Chemical Biology and Fundamental Medicine
- Novosibirsk State University
- Issue: Vol 81, No 3 (2016)
- Pages: 233-241
- Section: Article
- URL: https://journals.rcsi.science/0006-2979/article/view/150798
- DOI: https://doi.org/10.1134/S0006297916030056
- ID: 150798
Cite item
Abstract
The combined action of reactive metabolites of benzo[a]pyrene (B[a]P) and oxidative stress can lead to cluster-type DNA damage that includes both a bulky lesion and an apurinic/apyrimidinic (AP) site, which are repaired by the nucleotide and base excision repair mechanisms — NER and BER, respectively. Interaction of NER protein XPC—RAD23B providing primary damage recognition with DNA duplexes containing a B[a]P-derived residue linked to the exocyclic amino group of a guanine (BPDE-N2-dG) in the central position of one strand and AP site in different positions of the other strand was analyzed. It was found that XPC—RAD23B crosslinks to DNA containing (+)-trans-BPDE-N2-dG more effectively than to DNA containing cis-isomer, independently of the AP site position in the opposite strand; protein affinity to DNA containing one of the BPDE-N2-dG isomers depends on the AP site position in the opposite strand. The influence of XPC—RAD23B on hydrolysis of an AP site clustered with BPDE-N2-dG catalyzed by the apurinic/apyrimidinic endonuclease 1 (APE1) was examined. XPC—RAD23B was shown to stimulate the endonuclease and inhibit the 3′–5′ exonuclease activity of APE1. These data demonstrate the possibility of cooperation of two proteins belonging to different DNA repair systems in the repair of cluster-type DNA damage.
About the authors
L. V. Starostenko
Institute of Chemical Biology and Fundamental Medicine
Email: nadyarec@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090
E. A. Maltseva
Institute of Chemical Biology and Fundamental Medicine
Email: nadyarec@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090
N. A. Lebedeva
Institute of Chemical Biology and Fundamental Medicine; Novosibirsk State University
Email: nadyarec@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090
P. E. Pestryakov
Institute of Chemical Biology and Fundamental Medicine
Email: nadyarec@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090
O. I. Lavrik
Institute of Chemical Biology and Fundamental Medicine; Novosibirsk State University
Email: nadyarec@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090
N. I. Rechkunova
Institute of Chemical Biology and Fundamental Medicine; Novosibirsk State University
Author for correspondence.
Email: nadyarec@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090
![](/img/style/loading.gif)